Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Brightling

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Allergy|July 1, 2022
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbationSarah Diver, Koirobi Haldar, Pamela Jane McDowell, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
The European Respiratory Journal|May 28, 2016
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomographyDeepak R Subramanian, Sumit Gupta, Dorothe Burggraf, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
The European Respiratory Journal|February 20, 2025
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitationEnya Daynes, Rachael A Evans, Neil J Greening, et al.
Ebiomedicine|December 21, 2022
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Shubha Talwar, Andy Cross, et al.
Trials|January 26, 2023
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortiumEnya Daynes, Molly Baldwin, Neil J Greening, et al.
Trials|February 8, 2023
Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortiumEnya Daynes, Molly Baldwin, Neil J Greening, et al.
Scientific Reports|June 19, 2021
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytesAnna Esteve-Codina, Thomas P Hofer, Dorothe Burggraf, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Allergy|July 1, 2022
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbationSarah Diver, Koirobi Haldar, Pamela Jane McDowell, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
The European Respiratory Journal|May 28, 2016
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomographyDeepak R Subramanian, Sumit Gupta, Dorothe Burggraf, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
The European Respiratory Journal|February 20, 2025
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitationEnya Daynes, Rachael A Evans, Neil J Greening, et al.
Ebiomedicine|December 21, 2022
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Shubha Talwar, Andy Cross, et al.
Trials|January 26, 2023
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortiumEnya Daynes, Molly Baldwin, Neil J Greening, et al.
Trials|February 8, 2023
Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortiumEnya Daynes, Molly Baldwin, Neil J Greening, et al.
Scientific Reports|June 19, 2021
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytesAnna Esteve-Codina, Thomas P Hofer, Dorothe Burggraf, et al.
Pageof 8